Lifetime risk predictions for cardiovascular diseases: Competing risks analyses on a population-based cohort in

Anna Stenling1, Christel Häggström2, Margareta Norberg1

  • 1Department of Epidemiology and Global Health, Umeå University, 901 87, Umeå, Sweden.

Atherosclerosis
|October 4, 2020
PubMed

Insights

This study developed lifetime cardiovascular disease (CVD) risk models. The models accurately estimate individual risks for specific CVD events based on modifiable risk factors.

Area of Science:

  • Cardiology
  • Public Health
  • Epidemiology

Background:

  • Current cardiovascular disease (CVD) risk models primarily estimate short-term risks.
  • There is a need for models that assess lifetime CVD risk for a comprehensive approach.

Purpose of the Study:

  • To develop and validate lifetime risk models for specific cardiovascular events including coronary heart disease, stroke, and heart failure.
  • To provide diagnosis-specific lifetime risk estimates for various risk factor profiles.

Main Methods:

  • Utilized data from 92,915 individuals participating in a lifestyle intervention program.
  • Employed parametric multivariable survival regression with a competing risks approach.
  • Modeled cause-specific hazards and translated them into cumulative incidence functions for gender-age specific analyses.

Main Results:

  • Men exhibited a higher risk of cardiovascular events occurring at younger ages compared to women.
  • Modifying key risk factors like cholesterol, smoking, and blood pressure significantly impacted CVD event rates in simulated risk profiles.
  • The developed models demonstrated the substantial influence of modifiable risk factors on long-term CVD risk.

Conclusions:

  • The developed models enable accurate estimation of lifetime risk for individual cardiovascular events.
  • These diagnosis-specific predictions offer a more precise tool for personalized cardiovascular risk assessment.
  • The findings underscore the importance of addressing modifiable risk factors for long-term cardiovascular health.
Abstract

Related Concept Videos

Relative Risk01:12

Relative Risk

Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
1.5K
Actuarial Approach01:20

Actuarial Approach

The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
217
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
287
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
293
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
557
Introduction To Survival Analysis01:18

Introduction To Survival Analysis

Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
568